Trilobio

Trilobio

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $4.2M

Overview

Trilobio is an early-stage biotech automation company offering a comprehensive 'self-driving lab' platform designed to overcome the cost, complexity, and inflexibility of traditional lab automation. Its core technology includes the Trilobot, a benchtop robotic arm with auto-calibration and tool-changing capabilities, and the Trilobio OS, a no-code software for protocol design and fleet management. By targeting the significant pain points of manual research and expensive, siloed automation systems, Trilobio aims to democratize advanced automation for academic labs, biotech startups, and research organizations, thereby increasing reproducibility, throughput, and data production.

AI / Machine LearningDrug Discovery

Technology Platform

Integrated lab automation platform featuring the Trilobot (modular, auto-calibrating robotic arm with tool-changing) and Trilobio OS (no-code, biology-centric protocol design and execution software), supported by an open hardware/software ecosystem.

Funding History

1
Total raised:$4.2M
Seed$4.2M

Opportunities

Large, underserved market of academic and small-to-midsize biotech labs needing affordable, flexible automation.
The rise of AI-driven drug discovery creates demand for high-throughput, reproducible data generation that Trilobio's platform can enable.
An open ecosystem strategy could accelerate platform adoption and lock-in through network effects.

Risk Factors

Execution risk in manufacturing and scaling reliable hardware.
Market risk in convincing conservative biologists to adopt a new platform.
Competitive risk from large incumbents and agile startups.
Financial risk as a pre-profit, VC-dependent company in a capital-intensive sector.

Competitive Landscape

Competes against high-cost, integrated systems from large players like Thermo Fisher and Beckman Coulter, as well as other startups aiming to democratize lab automation. Differentiation lies in the combined no-code software, auto-calibration, tool-changing hardware, and open ecosystem at an affordable price point.